Jeffrey Recknagel, MD
Orthopaedic Surgery · Muskegon, MINPI 1184687147
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $5,899 of the $8,394 with a category attached, or 70.3%. Catalyst Orthoscience accounts for 79.7% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2022 at $2,250 and has fallen 94.6% since, to $122 in 2025.
Across 23 payments — averaging $364.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Catalyst Orthoscience$7K
- Arthrex$2K
- Medtronic$54
- Stryker$40
- Pacira Therapeutics, Inc.$34
- Avanos Medical$30
- plus $44 from 2 others
Across 7 payments — averaging $95,968 each. An ownership or investment interest held by the physician or an immediate family member.
- Catalyst Orthoscience$672K
What the payments were for
- Consulting fees$5,89970%
- Speaking & faculty fees$1,50018%
- Travel & lodging$3925%
- Food & beverage$6047%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Catalyst Orthoscience | 12 | $6,693 |
| Arthrex | 1 | $1,500 |
| Medtronic | 2 | $54 |
| Stryker | 2 | $40 |
| Pacira Therapeutics, Inc. | 3 | $34 |
| Avanos Medical | 1 | $30 |
| Abbott | 1 | $26 |
| Nalu Medical, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,394 in reported general payments places this provider in the 70th percentile of 829 orthopaedic surgery providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 118 | $1,607 |
| Ondansetron OdtOndansetron | 68 | $760 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 159 | $687 |
| Pregabalin | 123 | $470 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 92 | $335 |
| Meloxicam | 47 | $153 |
| Amoxicillin | 119 | $95 |
| Cephalexin | 83 | $93 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 15 | $66 |
| Clindamycin Hcl | 26 | $25 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Muskegon
- Anthony BozzioMuskegon$518K
- Asheesh BediAnn Arbor$9.4M
- Jerome WiaterBeverly Hills$3.9M
- Mark PintoChelsea$3.2M
- Kyle AndersonBingham Farms$3.1M
- Stephen BartolDetroit$2.6M
- Jad KhalilSouthfield$1.9M
- Jeffrey FischgrundSouthfield$1.8M
- John BlahaAnn Arbor$1.5M
- David MarkelSouthfield$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.